rheumatology
Medicines

Experts give their views on infection risk with biologics

A comprehensive review of infection risk in patients on targeted and biologic therapies for rheumatoid or psoriatic arthritis has reinforced the complexity of attributing risk to specific agents. The review, published in Annals of the Rheumatic Diseases, notes that RA and PsA per se are associated with an increased infectious risk and highlights the additional ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic